Jeonjinbio Co., Ltd. (KOSDAQ:110020)

Jeonjinbio Revenue

In the year 2025, Jeonjinbio had annual revenue of 13.69B KRW, down -28.94%. Jeonjinbio had revenue of 3.44B in the quarter ending December 31, 2025, a decrease of -21.81%.

• Revenue: 13.69B
• Revenue Growth: -28.94%
• P/S Ratio: 1.57
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 21.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.69B	-5.58B	-28.94%
Dec 31, 2024	19.27B	3.59B	22.91%
Dec 31, 2023	15.68B	7.89B	101.18%
Dec 31, 2022	7.79B	4.58B	142.48%
Dec 31, 2021	3.21B	-652.23M	-16.87%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 27, 2026

Data Sources Report a data error